View Item 

Show simple item record

Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports
dc.contributor.authorSweet, Kevin
dc.contributor.authorSturm, Amy C.
dc.contributor.authorSchmidlen, Tara
dc.contributor.authorMcElroy, Joseph
dc.contributor.authorScheinfeldt, Laura
dc.contributor.authorManickam, Kandamurugu
dc.contributor.authorGordon, Erynn S.
dc.contributor.authorHovick, Shelly
dc.contributor.authorScott Roberts, J.
dc.contributor.authorToland, Amanda Ewart
dc.contributor.authorChristman, Michael
dc.date.accessioned2019-01-15T20:28:44Z
dc.date.available2019-01-15T20:28:44Z
dc.date.issued2017-10
dc.identifier.citationSweet, Kevin; Sturm, Amy C.; Schmidlen, Tara; McElroy, Joseph; Scheinfeldt, Laura; Manickam, Kandamurugu; Gordon, Erynn S.; Hovick, Shelly; Scott Roberts, J.; Toland, Amanda Ewart; Christman, Michael (2017). "Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports." Journal of Genetic Counseling 26(5): 980-998.
dc.identifier.issn1059-7700
dc.identifier.issn1573-3599
dc.identifier.urihttps://hdl.handle.net/2027.42/147048
dc.description.abstractThere has been very limited study of patients with chronic disease receiving potentially actionable genomic based results or the utilization of genetic counselors in the online result delivery process. We conducted a randomized controlled trial on 199 patients with chronic disease each receiving eight personalized and actionable complex disease reports online. Primary study aims were to assess the impact of in‐person genomic counseling on 1) causal attribution of disease risk, 2) personal awareness of disease risk, and 3) perceived risk of developing a particular disease. Of 98 intervention arm participants (mean age = 57.8; 39% female) randomized for in‐person genomic counseling, 76 (78%) were seen. In contrast, control arm participants (n = 101; mean age = 58.5; 54% female) were initially not offered genomic counseling as part of the study protocol but were able to access in‐person genomic counseling, if they requested it, 3‐months post viewing of at least one test report and post‐completion of the study‐specific follow‐up survey. A total of 64 intervention arm and 59 control arm participants completed follow‐up survey measures. We found that participants receiving in‐person genomic counseling had enhanced objective understanding of the genetic variant risk contribution for multiple complex diseases. Genomic counseling was associated with lowered participant causal beliefs in genetic influence across all eight diseases, compared to control participants. Our findings also illustrate that for the majority of diseases under study, intervention arm participants believed they knew their genetic risk status better than control arm subjects. Disease risk was modified for the majority during genomic counseling, due to the assessment of more comprehensive family history. In conclusion, for patients receiving personalized and actionable genomic results through a web portal, genomic counseling enhanced their objective understanding of the genetic variant risk contribution to multiple common diseases. These results support the development of additional genomic counseling interventions to ensure a high level of patient comprehension and improve patient‐centered health outcomes.
dc.publisherSpringer US
dc.publisherWiley Periodicals, Inc.
dc.subject.otherRisk perception
dc.subject.otherGenetic
dc.subject.otherCounseling
dc.subject.otherComplex disease
dc.subject.otherCausal beliefs
dc.subject.otherGenomic
dc.titleOutcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHuman Genetics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/147048/1/jgc40980.pdf
dc.identifier.doi10.1007/s10897-017-0073-z
dc.identifier.sourceJournal of Genetic Counseling
dc.identifier.citedreferenceMyers, R. H., Kiely, D. K., Cupples, L. A., & Kannel, W. B. ( 1990 ). Parental history is an independent risk factor for coronary artery disease: the Framingham study. American Heart Journal, 120 ( 4 ), 963 – 969.
dc.identifier.citedreferenceKasparian, N. A., Wakefield, C. E., & Meiser, B. ( 2007 ). Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. Journal of Genetic Counseling, 16 ( 6 ), 693 – 712.
dc.identifier.citedreferenceKaufman, D. J., Bollinger, J. M., Dvoskin, R. L., & Scott, J. A. ( 2012 ). Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. Journal of Genetic Counseling, 21 ( 3 ), 413 – 422. doi:10.1007/s10897‐012‐9483‐0.
dc.identifier.citedreferenceKeller M, Gordon E, Stack C, et al. ( 2010 ). Coriell Personalized Medicine Collaborative ®: a prospective study of the utility of personalized medicine. Personalized Medicine, 7 ( 3 ), 301 – 317.
dc.identifier.citedreferenceLautenbach, D. M., Christensen, K. D., Sparks, J. A., & Green, R. C. ( 2013 ). Communicating genetic risk information for common disorders in the era of genomic medicine. Annual Review of Genomics and Human Genetics, 14, 491 – 513. doi:10.1146/annurev‐genom‐092010‐110722.
dc.identifier.citedreferenceLewis, K. L., Hooker, G. W., Connors, P. D., Hyams, T. C., Wright, M. F., Caldwell, S., et al. ( 2015 ). Participant use and communication of findings from exome sequencing: a mixed‐methods study. Genetics in Medicine. doi:10.1038/gim.2015.133.
dc.identifier.citedreferenceLipkus, I. M., Samsa, G., & Rimer, B. K. ( 2001 ). General performance on a numeracy scale among highly educated samples. Medical Decision Making, 21 ( 1 ), 37 – 44.
dc.identifier.citedreferenceMarteau, T. M., & Weinman, J. ( 2006 ). Self‐regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Social Science & Medicine, 62 ( 6 ), 1360 – 1368. doi:10.1016/j.socscimed.2005.08.005.
dc.identifier.citedreferenceMcBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. ( 2009 ). Characteristics of users of online personalized genomic risk assessments: implications for physician‐ patient interactions. Genetics in Medicine, 11 ( 8 ), 582 – 587. doi: 10.1097/GIM.0b013e3181b22c3a.
dc.identifier.citedreferenceMcBride, C. M., Birmingham, W. C., & Kinney, A. Y. ( 2015 ). Health psychology and translational genomic research: bringing innovation to cancer‐related behavioral interventions. The American Psychologist, 70 ( 2 ), 91 – 104. doi:10.1037/a0036568.
dc.identifier.citedreferenceMcInerney‐Leo, A., Hadley, D., Kase, R. G., Giambarresi, T. R., Struewing, J. P., & Biesecker, B. B. ( 2006 ). BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening. American Journal of Medical Genetics. Part A, 140 ( 20 ), 2198 – 2206. doi:10.1002/ajmg.a.31432.
dc.identifier.citedreferenceMiddleton, A., Hall, G., & Patch, C. ( 2015 ). Genetic counselors and genomic counseling in the United Kingdom. Molecular Genetics & Genomic Medicine, 3 ( 2 ), 79 – 83. doi:10.1002/mgg3.123.
dc.identifier.citedreferenceMills, R., & Haga, S. B. ( 2014 ). Genomic counseling: next generation counseling. Journal of Genetic Counseling, 23 ( 4 ), 689 – 692. doi: 10.1007/s10897‐013‐9641‐z.
dc.identifier.citedreferenceNational Society of Genetic Counselors’ Definition Task Force, Resta, R., Biesecker, B. B., Bennett, R. L., Blum, S., Hahn, S. E., et al. ( 2006 ). A new definition of genetic counseling: National Society of genetic Counselors’ task force report. Journal of Genetic Counseling, 15 ( 2 ), 77 – 83. doi: 10.1007/s10897‐005‐9014‐3.
dc.identifier.citedreferenceO’Daniel, J. M. ( 2010 ). The prospect of genome‐guided preventive medicine: a need and opportunity for genetic counselors. Journal of Genetic Counseling, 19 ( 4 ), 315 – 327. doi:10.1007/s10897‐010‐9302‐4.
dc.identifier.citedreferenceO’Neill, S. C., McBride, C. M., Alford, S. H., & Kaphingst, K. A. ( 2010 ). Preferences for genetic and behavioral health information: the impact of risk factors and disease attributions. Annals of Behavioral Medicine, 40 ( 2 ), 127 – 137. doi:10.1007/s12160‐010‐9197‐1.
dc.identifier.citedreferencePayne, K., Nicholls, S., McAllister, M., Macleod, R., Donnai, D., & Davies, L. M. ( 2008 ). Outcome measurement in clinical genetics services: a systematic review of validated measures. Value in Health, 11 ( 3 ), 497 – 508.
dc.identifier.citedreferenceRoberts, J. S., Dolinoy, D. C., & Tarini, B. A. ( 2014 ). Emerging issues in public health genomics. Annual Review of Genomics and Human Genetics, 15, 461 – 480. doi:10.1146/annurev‐genom‐090413‐025514.
dc.identifier.citedreferenceSanderson, S. C., O’Neill, S. C., White, D. B., Bepler, G., Bastian, L., Lipkus, I. M., & McBride, C. M. ( 2009 ). Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study. Cancer Epidemiology, Biomarkers & Prevention, 18 ( 7 ), 1953 – 1961.
dc.identifier.citedreferenceSchmidlen, T., Gordon, E. S., & Christman, M. F. ( 2009 ). Genomic Literacy: Emerging Themes Among Genetic Counseling Inquiries From Participants of the Coriell Personalized Medicine Collaborative. Paper presented at the From 28th Annual Education Conference of the National Society of Genetic Counselors., Atlanta, Georgia.
dc.identifier.citedreferenceSchmidlen, T., Wawak, L., Kasper, R., Garcia‐Espana, J. F., Christman, M. F., & Gordon, E. S. ( 2014 ). Personalized genomic results: analysis of informational needs. Journal of Genetic Counseling, 23 ( 4 ), 578 – 587. doi:10.1007/s10897‐014‐9693‐8.
dc.identifier.citedreferenceSchmidlen, T. J., Scheinfeldt, L., Zhaoyang, R., Kasper, R., Sweet, K., Gordon, E. S., et al. ( 2016 ). Genetic knowledge among participants in the Coriell personalized medicine collaborative. Journal of Genetic Counseling, 25 ( 2 ), 385 – 394. doi:10.1007/s10897‐015‐9883‐z.
dc.identifier.citedreferenceShelton, C. A., & Whitcomb, D. C. ( 2015 ). Evolving roles for physicians and genetic counselors in managing complex genetic disorders. Clinical Translational Gastroenterology, 6, e124. doi:10.1038/ctg.2015.46.
dc.identifier.citedreferenceShiloh, S., deHeer, H. D., Peleg, S., Hensley Alford, S., Skapinsky, K., Roberts, J. S., & Hadley, D. W. ( 2015 ). The impact of multiplex genetic testing on disease risk perceptions. Clinical Genetics, 87 ( 2 ), 117 – 123. doi:10.1111/cge.12403.
dc.identifier.citedreferenceSmerecnik, C. M., Mesters, I., Verweij, E., de Vries, N. K., & de Vries, H. ( 2009 ). A systematic review of the impact of genetic counseling on risk perception accuracy. Journal of Genetic Counseling, 18 ( 3 ), 217 – 228. doi:10.1007/s10897‐008‐9210‐z.
dc.identifier.citedreferenceSweet, K., Gordon, E. S., Sturm, A. C., Schmidlen, T. J., Manickam, K., Toland, A. E., et al. ( 2014 ). Design and implementation of a ran‐domized controlled trial of genomic counseling for patients with chronic disease. Journal of Perinatal Medicine, 4 ( 1 ), 1 – 19. doi:10.3390/jpm4010001.
dc.identifier.citedreferenceSweet, K., Sturm, A. C., Rettig, A., McElroy, J., & Agnese, D. ( 2015 ). Clinically relevant lessons from family HealthLink: a cancer and coronary heart disease familial risk assessment tool. Genetics in Medicine, 17 ( 6 ), 493 – 500. doi:10.1038/gim.2014.136.
dc.identifier.citedreferenceSweet, K., Sturm, A. C., Schmidlen, T., Hovick, S., Peng, J., Manickam, K., et al. ( 2016 ). EMR documentation of physician‐patient commu‐nication following genomic counseling for actionable complex disease and pharmacogenomic results. Clinical Genetics. doi: 10.1111/cge.12820.
dc.identifier.citedreferenceTrepanier, A. M., & Allain, D. C. ( 2014 ). Models of service delivery for cancer genetic risk assessment and counseling. Journal of Genetic Counseling, 23 ( 2 ), 239 – 253. doi:10.1007/s10897‐013‐9655‐6.
dc.identifier.citedreferenceVassy, J. L., O’Brien, K. E., Waxler, J. L., Park, E. R., Delahanty, L. M., Florez, J. C., et al. ( 2012 ). Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing. Medical Decision Making, 32 ( 4 ), 606 – 615. doi:10.1177/0272989X11431608.
dc.identifier.citedreferenceVeach, P. M., Bartels, D. M., & Leroy, B. S. ( 2007 ). Coming full circle: a reciprocal‐engagement model of genetic counseling practice. Journal of Genetic Counseling, 16 ( 6 ), 713 – 728. doi:10.1007/s10897‐007‐9113‐4.
dc.identifier.citedreferenceAbraha, I., & Montedori, A. ( 2010 ). Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ, 340, c2697. doi: 10.1136/bmj.c2697.
dc.identifier.citedreferenceArmstrong, J., Toscano, M., Kotchko, N., Friedman, S., Schwartz, M. D., Virgo, K. S., et al. ( 2015 ). Utilization and outcomes of BRCA genetic testing and counseling in a National Commercially Insured Population: the ABOUT study. JAMA Oncology, 1 – 10. doi: 10.1001/jamaoncol.2015.3048.
dc.identifier.citedreferenceAshida, S., Koehly, L. M., Roberts, J. S., Chen, C. A., Hiraki, S., & Green, R. C. ( 2010 ). The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL study. European Journal of Human Genetics, 18 ( 12 ), 1296 – 1301. doi:10.1038/ejhg.2010.119.
dc.identifier.citedreferenceAshida, S., Goodman, M., Pandya, C., Koehly, L. M., Lachance, C., Stafford, J., & Kaphingst, K. A. ( 2011 ). Age differences in genetic knowledge, health literacy and causal beliefs for health conditions. Public Health Genomics, 14 ( 4–5 ), 307 – 316. doi:10.1159/000316234.
dc.identifier.citedreferenceAustin, J. ( 2015 ). The effect of genetic test‐based risk information on behavioral outcomes: a critical examination of failed trials and a call to action. American Journal of Medical Genetics. Part A, 167 ( 12 ), 2913 – 2915. doi:10.1002/ajmg.a.37289.
dc.identifier.citedreferenceBenjamini, Y. H. Y. ( 1995 ). Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B: Methodological, 57 ( 1 ), 289 – 300.
dc.identifier.citedreferenceBirch, P. H. ( 2015 ). Interactive e‐counselling for genetics pre‐test decisions: where are we now? Clinical Genetics, 87 ( 3 ), 209 – 217. doi: 10.1111/cge.12430.
dc.identifier.citedreferenceBloss, C. S., Darst, B. F., Topol, E. J., & Schork, N. J. ( 2011 ). Direct‐to‐consumer personalized genomic testing. Human Molecular Genetics, 20 ( R2 ), R132 – R141. doi:10.1093/hmg/ddr349.
dc.identifier.citedreferenceBloss, C. S., Wineinger, N. E., Darst, B. F., Schork, N. J., & Topol, E. J. ( 2013 ). Impact of direct‐to‐consumer genomic testing at long term follow‐up. Journal of Medical Genetics, 50 ( 6 ), 393 – 400. doi:10.1136/jmedgenet‐2012‐101207.
dc.identifier.citedreferenceCameron, L. D., Marteau, T. M., Brown, P. M., Klein, W. M., & Sherman, K. A. ( 2012 ). Communication strategies for enhancing understanding of the behavioral implications of genetic and biomarker tests for disease risk: the role of coherence. Journal of Behavioral Medicine, 35 ( 3 ), 286 – 298. doi:10.1007/s10865‐011‐9361‐5.
dc.identifier.citedreferenceChristianson, C. A., Powell, K. P., Hahn, S. E., Bartz, D., Roxbury, T., Blanton, S. H., et al. ( 2010 ). Findings from a community education needs assessment to facilitate the integration of genomic medicine into primary care. Genetics in Medicine, 12 ( 9 ), 587 – 593. doi: 10.1097/GIM.0b013e3181ed3f97.
dc.identifier.citedreferenceClason, D. L., & Dormody, T. J. ( 1994 ). Analyzing data measured by individual Likert‐type items. Journal of Agricultural Education, 35 ( 4 ), 31 – 35.
dc.identifier.citedreferenceCondit, C. M., & Shen, L. ( 2011 ). Public understanding of risks from gene‐environment interaction in common diseases: implications for public communications. Public Health Genomics, 14 ( 2 ), 115 – 124. doi: 10.1159/000314915.
dc.identifier.citedreferenceCronbach, L. J., & Warrington, W. G. ( 1951 ). Time‐limit tests: estimating their reliability and degree of speeding. Psychometrika, 16 ( 2 ), 167 – 188.
dc.identifier.citedreferenceDeMarco, T. A., Peshkin, B. N., Mars, B. D., & Tercyak, K. P. ( 2004 ). Patient satisfaction with cancer genetic counseling: a psychometric analysis of the genetic counseling satisfaction scale. Journal of Genetic Counseling, 13 ( 4 ), 293 – 304.
dc.identifier.citedreferenceDewey, F. E., Chen, R., Cordero, S. P., Ormond, K. E., Caleshu, C., Karczewski, K. J., et al. ( 2011 ). Phased whole‐genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genetics, 7 ( 9 ), e1002280. doi:10.1371/journal.pgen.1002280.
dc.identifier.citedreferenceEichler, E. E., Flint, J., Gibson, G., Kong, A., Leal, S. M., Moore, J. H., & Nadeau, J. H. ( 2010 ). Missing heritability and strategies for finding the underlying causes of complex disease. Nature Reviews. Genetics, 11 ( 6 ), 446 – 450. doi:10.1038/nrg2809.
dc.identifier.citedreferenceFurr, L. A., & Kelly, S. E. ( 1999 ). The genetic knowledge index: developing a standard measure of genetic knowledge. Genetic Testing, 3 ( 2 ), 193 – 199.
dc.identifier.citedreferenceGollust, S. E., Gordon, E. S., Zayac, C., Griffin, G., Christman, M. F., Pyeritz, R. E., et al. ( 2012 ). Motivations and perceptions of early adopters of personalized genomics: perspectives from research par‐ticipants. Public Health Genomics, 15 ( 1 ), 22 – 30. doi:10.1159/000327296.
dc.identifier.citedreferenceGordon, E. S., Griffin, G., Wawak, L., Pang, H., Gollust, S. E., & Bernhardt, B. A. ( 2012 ). “It’s not like judgment day”: public under‐standing of and reactions to personalized genomic risk information. Journal of Genetic Counseling, 21 ( 3 ), 423 – 432. doi:10.1007/s10897‐011‐9476‐4.
dc.identifier.citedreferenceGupta, S. K. ( 2011 ). Intention‐to‐treat concept: a review. Perspectives in Clinical Research, 2 ( 3 ), 109 – 112. doi:10.4103/2229‐3485.83221.
dc.identifier.citedreferenceHaga, S. B. ( 2014 ). Delivering pharmacogenetic testing to the masses: an achievable goal? Pharmacogenomics, 15 ( 1 ), 1 – 4. doi:10.2217/pgs.13.211.
dc.identifier.citedreferenceHaga, S. B., Barry, W. T., Mills, R., Ginsburg, G. S., Svetkey, L., Sullivan, J., & Willard, H. F. ( 2013 ). Public knowledge of and attitudes toward genetics and genetic testing. Genetic Testing and Molecular Biomarkers, 17 ( 4 ), 327 – 335. doi:10.1089/gtmb.2012.0350.
dc.identifier.citedreferenceHaga, S. B., Barry, W. T., Mills, R., Svetkey, L., Suchindran, S., Willard, H. F., & Ginsburg, G. S. ( 2014 ). Impact of delivery models on understanding genomic risk for type 2 diabetes. Public Health Genomics, 17 ( 2 ), 95 – 104. doi:10.1159/000358413.
dc.identifier.citedreferenceHaukkala, A., Konttinen, H., Hankonen, N., Perola, M., Kaariainen, H., & Salomaa, V. ( 2015 ). Genetic causal beliefs about morbidity: associations with health behaviors and health outcome beliefs about behavior changes between 1982 and 2002 in the Finnish population. BMC Public Health, 15, 389. doi:10.1186/s12889‐015‐1657‐x.
dc.identifier.citedreferenceOrmond, K. E. ( 2013 ). From genetic counseling to “genomic counseling”. Molecular Genetics & Genomic Medicine, 1 ( 4 ), 189 – 193. doi:10.1002/mgg3.45.
dc.identifier.citedreferenceHeshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. ( 2008 ). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine, 10 ( 1 ), 19 – 32.
dc.identifier.citedreferenceInglis, A., Koehn, D., McGillivray, B., Stewart, S. E., & Austin, J. ( 2015 ). Evaluating a unique, specialist psychiatric genetic counseling clinic: uptake and impact. Clinical Genetics, 87 ( 3 ), 218 – 224. doi:10.1111/cge.12415.
dc.identifier.citedreferenceJallinoja, P., & Aro, A. R. ( 1999 ). Knowledge about genes and heredity among Finns. New Genetics and Society, 18 ( 1 ), 101 – 110.
dc.identifier.citedreferenceJenkins, J., Calzone, K. A., Dimond, E., Liewehr, D. J., Steinberg, S. M., Jourkiv, O., et al. ( 2007 ). Randomized comparison of phone versus in‐person BRCA1/2 predisposition genetic test result disclosure counseling. Genetics in Medicine, 9 ( 8 ), 487 – 495. doi:10.1097/GIM.0b013e31812e6220.
dc.identifier.citedreferenceJulian‐Reynier, C., Mancini, J., Mouret‐Fourme, E., Gauthier‐Villars, M., Bonadona, V., Berthet, P., et al. ( 2011 ). Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. European Journal of Human Genetics, 19 ( 5 ), 500 – 506. doi:10.1038/ejhg.2010.241.
dc.identifier.citedreferenceKaphingst, K. A., McBride, C. M., Wade, C., Alford, S. H., Reid, R., Larson, E., et al. ( 2012 ). Patients’ understanding of and responses to multiplex genetic susceptibility test results. Genetics in Medicine, 14 ( 7 ), 681 – 687. doi:10.1038/gim.2012.22.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jgc40980.pdf
Size:
932.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.